Yun Guo

Ganzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Application of chromosome microarray analysis and karyotyping in fetal cardiac abnormalities.

Application of chromosome microarray analysis and karyotyping in fetal cardiac abnormalities.

Journal: Frontiers in genetics

Published: April 14, 2025

NAT10-mediated ac4C modifications regulate glioblastoma progression.

NAT10-mediated ac4C modifications regulate glioblastoma progression.

Journal: Cell death & disease

Published: December 14, 2024

Positive feedback loop of c-myc/XTP6/NDH2/NF-κB to promote malignant progression in glioblastoma.

Positive feedback loop of c-myc/XTP6/NDH2/NF-κB to promote malignant progression in glioblastoma.

Journal: Journal of experimental & clinical cancer research : CR

Published: April 18, 2024

Targeting CB2R in astrocytes for Parkinson's disease therapy: unraveling the Foxg1-mediated neuroprotective mechanism through autophagy-mediated NLRP3 degradation.

Targeting CB2R in astrocytes for Parkinson's disease therapy: unraveling the Foxg1-mediated neuroprotective mechanism through autophagy-mediated NLRP3 degradation.

Journal: Journal of neuroinflammation

Published: August 25, 2023

CIA-II is associated with lower-grade glioma survival and cell proliferation.

CIA-II is associated with lower-grade glioma survival and cell proliferation.

Journal: CNS neuroscience & therapeutics

Published: March 29, 2023

Melatonin-Driven NLRP3 Inflammation Inhibition Via Regulation of NF-κB Nucleocytoplasmic Transport: Implications for Postoperative Cognitive Dysfunction.

Melatonin-Driven NLRP3 Inflammation Inhibition Via Regulation of NF-κB Nucleocytoplasmic Transport: Implications for Postoperative Cognitive Dysfunction.

Journal: Inflammation

Published: March 01, 2023

MAGOH is correlated with poor prognosis and is essential for cell proliferation in lower-grade glioma.

MAGOH is correlated with poor prognosis and is essential for cell proliferation in lower-grade glioma.

Journal: Aging

Published: February 10, 2023

DUSP10 is a novel immune-related biomarker connected with survival and cellular proliferation in lower-grade glioma.

DUSP10 is a novel immune-related biomarker connected with survival and cellular proliferation in lower-grade glioma.

Journal: Aging

Published: February 07, 2023

MGME1 associates with poor prognosis and is vital for cell proliferation in lower-grade glioma.

MGME1 associates with poor prognosis and is vital for cell proliferation in lower-grade glioma.

Journal: Aging

Published: February 06, 2023

PPP1R81 correlates with the survival and cell proliferation in lower-grade glioma.

PPP1R81 correlates with the survival and cell proliferation in lower-grade glioma.

Journal: Bioscience reports

Published: January 11, 2023

CNIH4: a novel biomarker connected with poor prognosis and cell proliferation in patients with lower-grade glioma.

CNIH4: a novel biomarker connected with poor prognosis and cell proliferation in patients with lower-grade glioma.

Journal: American journal of cancer research

Published: January 05, 2023

N6-methyladenosine (m6A)-connected lncRNAs are linked to survival and immune infiltration in glioma patients.

N6-methyladenosine (m6A)-connected lncRNAs are linked to survival and immune infiltration in glioma patients.

Journal: Bioscience reports

Published: October 07, 2022

Showing 1-12 of 14

Last Updated: 09/26/2026